Maxipime Cefepime 1g Injection Retail Pack from Germany
Branded Maxipime cefepime hydrochloride 1g powder in a retail-ready carton with diluent syringe for hospital use against resistant infections. It qualifies for HTS 3004.20.00.71 as a mixed/unmixed cefepime salt product in measured doses for therapeutic prophylactic uses. Packaging is designed for direct retail sale.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include branded labeling and PIL (patient information leaflet) equivalents for FDA import review
• Verify tariff shift rules if manufactured in FTZ; document cefepime content > principal ingredient
• Watch for misdeclaration as bulk chemical, ensuring retail packing proofs